N4 Pharma (GB:N4P) has released an update.
N4 Pharma has announced a collaborative deal with SRI International and will host an informative webinar on May 7, 2024, to discuss the partnership. The company specializes in a unique delivery system, Nuvec®, for cancer treatments and vaccines, and seeks to monetize this technology by partnering with developers of novel antigens to deliver their products. The webinar is aimed at investors, who are encouraged to engage and submit questions through the N4 Pharma Investor Hub.
For further insights into GB:N4P stock, check out TipRanks’ Stock Analysis page.
